Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Mod Pathol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    January 2017
  1. YOUSEF EM, Furrer D, Laperriere DL, Tahir MR, et al
    MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  2. VIEIRA AF, Dionisio MR, Gomes M, Cameselle-Teijeiro JF, et al
    P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  3. DOEBAR SC, Slaets L, Cardoso F, Giordano SH, et al
    Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    October 2016
  4. RUSCHOFF J, Lebeau A, Kreipe H, Sinn P, et al
    Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.
    Mod Pathol. 2016 Oct 21. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  5. BALLARD M, Jalikis F, Krings G, Schmidt RA, et al
    'Non-classical' HER2 FISH results in breast cancer: a multi-institutional study.
    Mod Pathol. 2016 Oct 14. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    August 2016
  6. SCHRIJVER WA, van der Groep P, Hoefnagel LD, Ter Hoeve ND, et al
    Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.
    Mod Pathol. 2016 Aug 26. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  7. KORNAGA EN, Klimowicz AC, Guggisberg N, Ogilvie T, et al
    Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.
    Mod Pathol. 2016 Aug 26. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  8. FUSCO N, Geyer FC, De Filippo MR, Martelotto LG, et al
    Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
    Mod Pathol. 2016 Aug 5. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    July 2016
  9. DENKERT C, Wienert S, Poterie A, Loibl S, et al
    Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
    Mod Pathol. 2016 Jul 1. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    April 2016
  10. KORNAGA EN, Klimowicz AC, Guggisberg N, Ogilvie T, et al
    A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort.
    Mod Pathol. 2016 Apr 29. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    March 2016
  11. WEISMAN PS, Ng CK, Brogi E, Eisenberg RE, et al
    Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology.
    Mod Pathol. 2016 Mar 4. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    February 2016
  12. HUO L, Wang Y, Gong Y, Krishnamurthy S, et al
    MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.
    Mod Pathol. 2016 Feb 26. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  13. STALHAMMAR G, Fuentes Martinez N, Lippert M, Tobin NP, et al
    Digital image analysis outperforms manual biomarker assessment in breast cancer.
    Mod Pathol. 2016 Feb 26. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    December 2015
  14. NAWAZ S, Heindl A, Koelble K, Yuan Y, et al
    Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer.
    Mod Pathol. 2015;28:1621.
    PubMed     Text format    


    March 2015
  15. WEIGELT B, Ng CK, Shen R, Popova T, et al
    Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. .
    Mod Pathol. 2015;28:340-51.
    PubMed     Text format     Abstract available


  16. STEWART J, James J, McCluggage GW, McQuaid S, et al
    Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.
    Mod Pathol. 2015;28:428-36.
    PubMed     Text format     Abstract available


  17. TAN WJ, Thike AA, Tan SY, Tse GM, et al
    CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
    Mod Pathol. 2015;28:352-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: